hydralazine has been researched along with Arteriovenous Malformations, Cerebral in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, Q | 1 |
| Su, H | 1 |
| Marchuk, DA | 1 |
| Rola, R | 1 |
| Wang, Y | 1 |
| Liu, W | 1 |
| Young, WL | 1 |
| Yang, GY | 1 |
1 other study available for hydralazine and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Animals; Brain; Capillaries; Cerebrovascular | 2008 |